APA (7th ed.) Citation

ME, E., JM, M., K, D., JC, C., LC, N., A, Z., & HJ, F. (2025). Advantages and challenges of using allogeneic vs. autologous sources for neuronal cell replacement in Parkinson's disease: Insights from non-human primate studies. Brain research bulletin, 224, 111297. https://doi.org/10.1016/j.brainresbull.2025.111297

Chicago Style (17th ed.) Citation

ME, Emborg, Metzger JM, D'Amour K, Colwell JC, Neumann LC, Zhang A, and Federoff HJ. "Advantages and Challenges of Using Allogeneic Vs. Autologous Sources for Neuronal Cell Replacement in Parkinson's Disease: Insights from Non-human Primate Studies." Brain Research Bulletin 224 (2025): 111297. https://doi.org/10.1016/j.brainresbull.2025.111297.

MLA (9th ed.) Citation

ME, Emborg, et al. "Advantages and Challenges of Using Allogeneic Vs. Autologous Sources for Neuronal Cell Replacement in Parkinson's Disease: Insights from Non-human Primate Studies." Brain Research Bulletin, vol. 224, 2025, p. 111297, https://doi.org/10.1016/j.brainresbull.2025.111297.